Vinay Prasad博士在面对政治压力和审查后辞去林业发展局生物研究中心的职务。 Dr. Vinay Prasad resigns from FDA's Center for Biologics after facing political pressure and scrutiny.

领导林业发展局生物评价和研究中心的Vinay Prasad博士在不到三个月后辞职。 Dr. Vinay Prasad, who headed the FDA's Center for Biologics Evaluation and Research, has resigned after less than three months. 他离开时受到保守派活动分子的批评和白宫的压力。 His departure follows criticism from conservative activists and pressure from the White House. 普拉萨德是FDA药物批准和疫情政策的公开批评者, 权利活动家劳拉·卢默指责他破坏了FDA. Prasad, a vocal critic of the FDA’s drug approvals and pandemic policies, was accused by right-wing activist Laura Loomer of undermining the FDA. 食品药品管理局专员Marty Makary博士赞美普拉萨德为“值得尊敬的科学家”, Despite facing scrutiny, FDA Commissioner Dr. Marty Makary praised Prasad as an "impeccable scientist." 这场争论围绕着他如何处理杜尚症肌肉萎缩的基因疗法以及他对疫苗审批的反感看法。 The controversy surrounded his handling of a gene therapy for Duchenne muscular dystrophy and his contrarian views on vaccine approvals.